Business · 03/08/2026

FDA Reopens Comment Period for Proposed Rule to Modify Terminology in Title 21

The Food and Drug Administration is extending the public comment period for a proposed rule aimed at updating terminology in the Code of Federal Regulations to align with a recent executive order, with the goal of improving readability and allowing more time for public input.